ReviewFrontiers in pediatrics2015

Beyond CD19: Opportunities for Future Development of Targeted Immunotherapy in Pediatric Relapsed-Refractory Acute Leukemia.

Haneen Shalabi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.